Characterization of SHP2 phosphatase as a therapeutic target in myeloproliferative neoplasms using an ex vivo bioreactor platform

被引：0
|
作者：
Vokalova, L. [1 ,2 ,3 ]
Garcia-Garcia, A. [2 ,3 ]
Reinhardt, E. [2 ,3 ]
Genty, L. [2 ,3 ]
Plantier, E. [2 ,3 ]
Jungius, S. [1 ,2 ,3 ]
Brkic, S. [2 ,3 ]
Rovo, A. [1 ]
Angelillo-Scherrer, A. [4 ,5 ]
Ivan, M. [2 ,3 ]
Meyer, S. C. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Bern, Dept Biomed Res, Inselspital Bern, Bern, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Univ Hosp Basel, Dept Biomed, Basel, Switzerland
[4] Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland
[5] Cent Hematol Lab, Bern, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P433
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [31] Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder
    Xu, Dan
    Zheng, Hong
    Yu, Wen-Mei
    Qu, Cheng-Kui
    PLOS ONE, 2013, 8 (05):
  • [32] SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling
    Nagamura, Yuko
    Miyazaki, Makoto
    Nagano, Yoshiko
    Tomiyama, Arata
    Ohki, Rieko
    Yanagihara, Kazuyoshi
    Sakai, Ryuichi
    Yamaguchi, Hideki
    CANCERS, 2021, 13 (17)
  • [33] HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
    Marubayashi, Sachie
    Koppikar, Priya
    Taldone, Tony
    Abdel-Wahab, Omar
    West, Nathan
    Bhagwat, Neha
    Caldas-Lopes, Eloisi
    Ross, Kenneth N.
    Goenen, Mithat
    Gozman, Alex
    Ahn, James H.
    Rodina, Anna
    Ouerfelli, Ouathek
    Yang, Guangbin
    Hedvat, Cyrus
    Bradner, James E.
    Chiosis, Gabriela
    Levine, Ross L.
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (10): : 3578 - 3593
  • [34] SHP2 Inhibition Suppresses RAS-ERK Signaling, the Development of JAK2 Inhibitor Persistence, and MPN Development in Pre-Clinical Models of Myeloproliferative Neoplasms
    Pandey, Garima
    Horvat, Nathan
    Amin, Narmin E.
    Zhang, Guolin
    Mazzacurati, Lucia
    Akuffo, Afua A.
    Colin-Leitzinger, Christelle
    Haura, Eric B.
    Epling-Burnette, Pearlie K.
    Reuther, Gary W.
    BLOOD, 2022, 140 : 9573 - 9574
  • [35] Protein tyrosine phosphatase non receptor 11 (PTPN11/Shp2) as a driver oncogene and a novel therapeutic target in non-small cell lung cancer (NSCLC).
    Elamin, Yasir
    Toomey, Sinead
    Carr, Aoife
    Gately, Kathy
    Rafee, Shereen
    Grogan, William
    Morris, Patrick G.
    Breathnach, Oscar S.
    Crown, John
    O'Byrne, Kenneth
    Hennessy, Bryan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Off-target autophagy inhibition by SHP2 allosteric inhibitors and therapeutic implications for aberrant RAS-driven cancers
    Miao, Yiming
    Bai, Yunpeng
    Miao, Jinmin
    Murray, Allison A.
    Lin, Jianping
    Dong, Jiajun
    Qu, Zihan
    Zhang, Ruo-Yu
    Nguyen, Quyen
    Wang, Shaomeng
    Zhang, Zhong-Yin
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Protein Tyrosine Phosphatase Non Receptor 11 PTPN11/Shp2 as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer NSCLC
    Elamin, Yasir
    Toomey, Sinead
    Carr, Aoife
    Gately, Kathy
    Rafee, Shereen
    Morris, Patrick
    Crown, John
    Breathnach, Oscar
    O'Byrne, Kenneth J.
    Hennessy, Bryan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S246 - S246
  • [38] The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo
    Nabinger, S. C.
    Li, X. J.
    Ramdas, B.
    He, Y.
    Zhang, X.
    Zeng, L.
    Richine, B.
    Bowling, J. D.
    Fukuda, S.
    Goenka, S.
    Liu, Z.
    Feng, G-S
    Yu, M.
    Sandusky, G. E.
    Boswell, H. S.
    Zhang, Z-Y
    Kapur, R.
    Chan, R. J.
    LEUKEMIA, 2013, 27 (02) : 398 - 408
  • [39] Therapeutic rationale for SHP2 phosphatase inhibitors: Targeting drug-resistant breast cancer via blockade of FGFR1 signaling
    Chen, Hao
    Zhang, Sheng
    Zhang, Zhong-Yin
    Wendt, Michael Keith
    CANCER RESEARCH, 2018, 78 (13)
  • [40] The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo
    S C Nabinger
    X J Li
    B Ramdas
    Y He
    X Zhang
    L Zeng
    B Richine
    J D Bowling
    S Fukuda
    S Goenka
    Z Liu
    G-S Feng
    M Yu
    G E Sandusky
    H S Boswell
    Z-Y Zhang
    R Kapur
    R J Chan
    Leukemia, 2013, 27 : 398 - 408
12345